PCSK9 Inhibitors
About the Procedure
PCSK9 Inhibitors are advanced lipid-lowering medications that significantly reduce LDL (‘bad’) cholesterol levels. They work by blocking the PCSK9 protein, allowing the liver to remove more LDL cholesterol from the blood. These injectable medications are especially useful for patients who cannot achieve target cholesterol levels with statins alone or who are statin-intolerant. PCSK9 Inhibitors lower the risk of heart attack and stroke and are used as part of long-term cardiovascular risk reduction strategies.
Relevant Specialties
Cardiology
Our Cardiology Department delivers prevention, diagnosis and treatment for heart diseases through personalised care and advanced technology. Risk clinics for blood pressure and lipids offer non-invasive testing (ECG, echocardiogram, treadmill stress test, Holter monitor, and ambulatory blood pressure monitoring) and provide interventional services in a modern Catheterisation Laboratory, including device therapy and structural procedures. We maintain 24/7 cardiac ICU coverage and consultant availability to ensure rapid treatment for acute events. Post-procedure, patients receive tailored rehabilitation and multidisciplinary support that spans diabetes, pulmonary, and genetic services.
